Indicators | FMC A | FMC B | FMC C | FMC D | Total |
---|---|---|---|---|---|
I. Process of care | n = 7184 % | n = 6671 % | n = 7256 % | n = 4019 % | n = 25130 % |
A. Timely detection of T2D complications and comorbidity in the last year | |||||
At least one measurement of HbA1c | 9.0 | 16.9 | Not available | Not available | 7.1 |
Comprehensive foot evaluation | 51.9 | 28.2 | 24.6 | 5.4 | 30.3 |
Referral to the ophthalmologist | 22.2 | 14.2 | 7.0 | 5.4 | 13.0 |
Screening for dyslipidemia by measuring total cholesterol in patients without previous diagnosis of dyslipidemia | 3653 | 3714 | 4336 | 2971 | 14674 |
65.4 | 54.7 | 45.6 | 70.0 | 57.8 | |
B. Non-pharmacological treatment in the last year | n | n | n | n | n |
% | % | % | % | % | |
Nutritional counseling provided by the nutrition service | 7184 | 6671 | 7256 | 4019 | 25130 |
1.8 | 5.5 | 4.9 | 3.0 | 3.9 | |
C. Pharmacological treatment in the last three visits | n | n | n | n | n |
% | % | % | % | % | |
Overweight/obese (BMI ≥ 25 kg/m2) patients who received metformin, unless contraindicated | 5066 | 4437 | 5216 | 2840 | 17559 |
57.2 | 63.0 | 66.7 | 67.6 | 63.2 | |
Patients with hypertension receiving inhibitors of angiotensin converting enzyme or angiotensin-receptor blocker, unless contraindicated | 4545 | 4536 | 4298 | 1787 | 15172 |
46.0 | 56.8 | 58.9 | 66.1 | 57.4 | |
Patients > 40 years of age with one or more of the following risk factors: smoking, hypertension, dyslipidemia, receiving 75-150 mg/day of acetylsalicylic acid, unless contraindicated | 5242 | 5035 | 4904 | 2076 | 17257 |
45.8 | 32.0 | 46.2 | 58.9 | 43.4 | |
Patient with total cholesterol >200 mg/dl and were prescribed statins, unless contraindicated | 2436 | 1998 | 2197 | 1233 | 7864 |
55.6 | 43.9 | 49.1 | 36.9 | 47.9 | |
II. Health outcomes | n | n | n | n | n |
% | % | % | % | % | |
HbA1c <7% or fasting glucose ≤130 mg/dl in the last 3 measurements | 4644 | 3560 | 4563 | 2816 | 15583 |
23.0 | 32.5 | 19.2 | 17.9 | 23.1 | |
Total cholesterol levels < 200 mg/dl in the last measurement | 5097 | 4168 | 4125 | 3008 | 16398 |
52.2 | 52.1 | 46.7 | 59.0 | 52.0 | |
Blood pressure <130/80 mmHg in the last 3 measurements | 7088 | 6587 | 7247 | 4011 | 24933 |
12.3 | 8.5 | 14.1 | 5.7 | 10.8 | |
Overweight/obese (BMI ≥ 25 kg/m2) patients who lost ≥5% body weight in the last year | 5066 | 4437 | 5216 | 2840 | 17559 |
13.4 | 14.7 | 12.6 | 12.5 | 13.3 | |
Patients with HbA1c <7%, or fasting glucose ≤130 mg/dl, total cholesterol levels < 200 mg/dl and blood pressure <130/80 mmHg in the last 3 measurements | 4272 | 3123 | 3479 | 2516 | 13390 |
1.8 | 1.7 | 1.2 | 0.6 | 1.4 |